Development of Small Interfering RNA-Loaded Extracellular Vesicles via a High-Pressure Homogenization Approach
ACS Applied Bio Materials · 03.08.2026 · 9 (15) · 7038-7052
DOI: 10.1021/acsabm.6c00676 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 16.07.2026. Verfasst von Tatsuya Fukuta und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Pharmaceutics, School of Pharmaceutical Sciences, Wakayama Medical University, 25-1 Shichiban-cho, Wakayama640-8156, Japan. Hauptthemen laut MEDLINE: RNA, Small Interfering, Extracellular Vesicles, Biocompatible Materials. Die Arbeit nennt 54 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Extracellular vesicles (EVs) have garnered significant interest as potential bioderived drug delivery systems for RNA therapeutics owing to their distinctive characteristics, which include their inherent capability to transport various biological molecules throughout the body. However, several issues still pose challenges, such as the limited loading of exogenous RNAs and poor scalability of conventional techniques. High-pressure homogenization (HPH) is a useful alternative for the scalable preparation of EVs encapsulating small-molecule therapeutic agents via a one-step pharmaceutical process. However, whether HPH can be applied to macromolecular drugs, such as small interfering RNA (siRNA), remains unclear. Herein, we report the applicability of using HPH to prepare siRNA-loaded EVs and their subsequent cytoplasmic siRNA delivery. Simultaneous HPH of bovine milk-derived EVs (mEVs) with distearoylphosphatidylethanolamine–polyethylene glycol–polyethyleneimine and cholesterol-conjugated siRNA allowed siRNA loading onto the mEVs. Modification of the mEVs with the tumor-targeting ligand, cyclo(Arg-Gly-Asp-d-Phe-Lys) (cRGD), showed high affinity for a human glioma cell line, resulting in remarkable intracellular siRNA delivery. Moreover, siRNA delivered with the cRGD-modified mEVs showed a higher knockdown efficiency than that of the unmodified mEVs. The present findings suggest, for the first time, that HPH holds potential for the development of siRNA-loaded EV therapeutics that could be useful for cytoplasmic siRNA delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physical Pharmaceutics, School of Pharmaceutical Sciences, Wakayama Medical University, 25-1 Shichiban-cho, Wakayama640-8156, Japan.
- Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1, Inohara, Chuo-ku, Chiba260-8675, Japan.
- Powrex Corporation , 5-5-5 Kita-Gawara, Itami, Hyogo664-0837, Japan.
ORCID-Profile: Tatsuya Fukuta, Mayumi Ikeda-Imafuku, Kenjirou Higashi, Kazunori Kadota
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
Zitieren
APA
Fukuta, T., Miyazaki, M., Fujimoto, T., Shibaguchi, K., Matsui, K., Ikeda-Imafuku, M., Higashi, K., & Kadota, K. (2026). Development of Small Interfering RNA-Loaded Extracellular Vesicles via a High-Pressure Homogenization Approach. ACS Applied Bio Materials, 9(15), 7038-7052. https://doi.org/10.1021/acsabm.6c00676
Vancouver
Fukuta T, Miyazaki M, Fujimoto T, Shibaguchi K, Matsui K, Ikeda-Imafuku M, et al. Development of Small Interfering RNA-Loaded Extracellular Vesicles via a High-Pressure Homogenization Approach. ACS Applied Bio Materials. 2026;9(15):7038-7052. doi:10.1021/acsabm.6c00676
BibTeX
@article{Fukuta2026,
author = {Fukuta, Tatsuya and Miyazaki, Masato and Fujimoto, Taiki and Shibaguchi, Kota and Matsui, Ko and Ikeda-Imafuku, Mayumi and Higashi, Kenjirou and Kadota, Kazunori},
title = {Development of Small Interfering RNA-Loaded Extracellular Vesicles via a High-Pressure Homogenization Approach},
journal = {ACS Applied Bio Materials},
year = {2026},
volume = {9},
number = {15},
pages = {7038--7052},
doi = {10.1021/acsabm.6c00676}
}
EUVIMED